Wednesday, April 15, 2026
Category

Investing

15 articles
Generate Biomedicines Sets IPO Price at $16 for Asthma Solutions
Featured26 Feb 2026

Generate Biomedicines Sets IPO Price at $16 for Asthma Solutions

Generate Biomedicines, an AI-driven biotech firm focused on asthma treatment, has successfully set its IPO price at $16. This funding will enhance its innovative research in immunology and oncology.

Read article

Latest

ARKO Petroleum Upsizes IPO to $18 Amid Strong Demand
Fintech12 Feb 2026

ARKO Petroleum Upsizes IPO to $18 Amid Strong Demand

ARKO Petroleum successfully priced its IPO at $18 per share, raising $200 million and highlighting its robust distribution network. The company aims for a Nasdaq listing under symbol APC.

Enphase Energy's Q4 2025 Financial Results Show Mixed Trends
Fintech3 Feb 2026

Enphase Energy's Q4 2025 Financial Results Show Mixed Trends

Enphase Energy's financial results for Q4 2025 reflect a revenue dip but strong demand for solar products. The company's strategies and market dynamics were highlighted by CEO Badri Kothandaraman.

Goldman Sachs Reports 2025 Financial Results, Eyes Growth Ahead
Fintech15 Jan 2026

Goldman Sachs Reports 2025 Financial Results, Eyes Growth Ahead

Goldman Sachs announced its financial results for 2025, boasting significant revenue and earnings performance. CEO David Solomon emphasized a strategy for growth and capital deployment in 2026.

US Equity Market Resilience Amid Turbulent Headlines
Fintech12 Jan 2026

US Equity Market Resilience Amid Turbulent Headlines

The US equity market remains strong despite rising geopolitical tensions and new policies. Analysts predict growth driven by underlying economic factors.

Goldman Sachs' 2026 Financial Market Outlook: US Resilience Maintained
Fintech12 Jan 2026

Goldman Sachs' 2026 Financial Market Outlook: US Resilience Maintained

Goldman Sachs' 2026 Economic and Financial Market Outlook emphasizes the continued resilience of the US economy amid various challenges. Despite market tumult in 2025, the financial giant remains optimistic about US equities.

Mercury Personal Launches to Public Without Waitlist
Fintech11 Dec 2025

Mercury Personal Launches to Public Without Waitlist

Mercury Personal has officially removed its waitlist, granting all users access to an innovative banking platform with enhanced features, including joint accounts and integrated investing options.

Resistant AI Secures $25M for Advanced Fraud Prevention Solutions
Fintech13 Oct 2025

Resistant AI Secures $25M for Advanced Fraud Prevention Solutions

Resistant AI raises $25 million in Series B funding led by DTCP to enhance its AI-driven fraud detection solutions. The investment aims to expand its offerings globally.

GM Reports Q4 2024 Financial Results and 2025 Outlook
Fintech27 Jan 2025

GM Reports Q4 2024 Financial Results and 2025 Outlook

General Motors released its financial results for Q4 2024, highlighting a net income loss due to significant restructuring charges. The company projects strong financial performance for 2025 amid ongoing industry challenges.

Goldman Sachs Reports Strong Q4 and 2024 Earnings Results
Fintech14 Jan 2025

Goldman Sachs Reports Strong Q4 and 2024 Earnings Results

Goldman Sachs has announced its earnings for the fourth quarter and full year of 2024, showcasing robust revenue and net income growth, significantly exceeding prior year figures.

Market Insights: Financial Trends on March 3, 2026
Fintech11 Dec 2024

Market Insights: Financial Trends on March 3, 2026

On March 3, 2026, major market trends indicate a high risk in trading CFDs and forex. Market participants must weigh the complexities of these instruments carefully.

Market Insights: Key Trends and Risks for March 2026
Fintech11 Dec 2024

Market Insights: Key Trends and Risks for March 2026

On March 10, 2026, the financial landscape shows significant risks for retail investors, especially in complex instruments like CFDs and forex. Analyzing market trends reveals a high level of volatility and investment caution.